DEA delays marijuana reform hearings, Virginia raises alarms on legalization, and studies show cannabis might ease anxiety meds reliance.
From delayed reforms to state-level resistance and groundbreaking studies, the cannabis debate continues to spark national attention
In today's edition, we explore significant developments shaping the cannabis landscape across the United States. The Drug Enforcement Administration (DEA) has canceled upcoming hearings on marijuana rescheduling, citing legal challenges—a move that delays anticipated reforms by several months. Concurrently, a DEA judge has criticized the agency's handli…
